| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.4B | $16.9B | $4.5B | $10.6B | $1.9B | $2.3B | $2.5B |
| Cost of Revenue | $10.1B | $11.9B | $16.2B | $19.3B | $10.5B | $7.5B | $8.4B | $9.3B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.3B | $0.2B |
| Operating Income | $0.2B | $-0.4B | $0.3B | $-0.1B | $-0.1B | $-0.3B | $0.0B | $0.2B |
| Net Income | $0.1B | $-0.4B | $0.0B | $-0.1B | $-0.2B | $-0.3B | $0.0B | $0.1B |
| EPS (Basic) | $-0.38 | $-8.77 | $0.30 | $-1.73 | $-2.75 | $-3.98 | $0.44 | $1.50 |
| EPS (Diluted) | $-0.38 | $-8.77 | $0.30 | $-1.73 | $-2.75 | $-3.98 | $0.44 | $1.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.8B | $6.7B | $7.2B | $8.2B | $6.7B | $6.1B | $7.0B | $5.8B |
| Current Assets | $2.1B | $2.3B | $2.7B | $3.7B | $2.9B | $2.3B | $3.0B | $2.4B |
| Cash & Equivalents | $0.6B | $0.7B | $0.8B | $0.8B | $0.9B | $0.8B | $1.0B | $1.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.5B | $2.5B | $2.7B | $3.1B | $3.1B | $1.9B | $2.4B | $1.7B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $-0.1B | $1.0B | $0.4B | $0.4B | $-0.3B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.7B | $-0.2B | $-0.4B | $-0.9B | $-0.2B | $-0.2B | $-0.7B | $-0.1B |
| Capital Expenditures | $0.5B | $0.4B | $0.4B | $0.3B | $0.2B | $0.3B | $0.4B | $0.3B |
| Financing Cash Flow | $0.1B | $0.2B | $-0.6B | $0.5B | $-0.1B | $0.3B | $-0.0B | $-0.3B |